Tay-Sachs disease prevention in Minnesota. Role of physician advocacy in carrier screening. 1986

D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008910 Minnesota State bordered on the north by Canada, on the east by Lake Superior and Wisconsin, on the south by Iowa, and on the west by North Dakota and South Dakota.
D010819 Physician's Role The expected function of a member of the medical profession. Physicians' Role,Physician Role,Physician's Roles,Physicians Role,Physicians' Roles,Role, Physician's,Role, Physicians',Roles, Physician's,Roles, Physicians'
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013661 Tay-Sachs Disease An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry. G(M2) Gangliosidosis, Type I,Gangliosidosis G(M2), Type I,Gangliosidosis GM2, B Variant,Hexosaminidase A Deficiency Disease,Tay-Sachs Disease, B Variant,Amaurotic Familial Idiocy,B Variant GM2 Gangliosidosis,B Variant GM2-Gangliosidosis,Deficiency Disease Hexosaminidase A,Familial Amaurotic Idiocy,GM2 Gangliosidosis, B Variant,GM2 Gangliosidosis, Type 1,GM2 Gangliosidosis, Type I,GM2-Gangliosidosis, Type I,Gangliosidosis GM2 , Type 1,Gangliosidosis GM2, Type I,HexA Deficiency,Hexosaminidase A Deficiency,Hexosaminidase alpha-Subunit Deficiency (Variant B),Sphingolipidosis, Tay-Sachs,Amaurotic Idiocy, Familial,B Variant GM2-Gangliosidoses,Deficiency, Hexosaminidase A,Deficiency, Hexosaminidase alpha-Subunit (Variant B),GM2-Gangliosidosis, B Variant,Hexosaminidase alpha Subunit Deficiency (Variant B),Sphingolipidosis, Tay Sachs,Tay Sachs Disease,Tay Sachs Disease, B Variant,Tay-Sachs Sphingolipidosis,Type I GM2-Gangliosidosis

Related Publications

D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
July 1990, Lancet (London, England),
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
April 1990, Lancet (London, England),
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
January 1998, Genetic testing,
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
October 1989, New York state journal of medicine,
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
January 1991, Nursing,
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
September 1978, Canadian Medical Association journal,
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
January 1977, Progress in clinical and biological research,
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
January 1977, Canadian journal of public health = Revue canadienne de sante publique,
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
June 1990, Lancet (London, England),
D J Lipsitz, and V E Anderson, and J F O'Brien, and R J Desnick
January 2000, Genetic testing,
Copied contents to your clipboard!